Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 18

1.

Muscle and fascicle excursion in children with cerebral palsy.

Matthiasdottir S, Hahn M, Yaraskavitch M, Herzog W.

Clin Biomech (Bristol, Avon). 2014 Apr;29(4):458-62. doi: 10.1016/j.clinbiomech.2014.01.002. Epub 2014 Jan 13.

PMID:
24485882
2.

Kinematic differences between gender specific and traditional knee implants.

Saevarsson SK, Sharma GB, Ramm H, Lieck R, Hutchison CR, Werle J, Matthiasdottir S, Montgomery SJ, Romeo CI, Zachow S, Anglin C.

J Arthroplasty. 2013 Oct;28(9):1543-50. doi: 10.1016/j.arth.2013.01.021. Epub 2013 Apr 25.

PMID:
23623459
3.

Common variants on 9q22.33 and 14q13.3 predispose to thyroid cancer in European populations.

Gudmundsson J, Sulem P, Gudbjartsson DF, Jonasson JG, Sigurdsson A, Bergthorsson JT, He H, Blondal T, Geller F, Jakobsdottir M, Magnusdottir DN, Matthiasdottir S, Stacey SN, Skarphedinsson OB, Helgadottir H, Li W, Nagy R, Aguillo E, Faure E, Prats E, Saez B, Martinez M, Eyjolfsson GI, Bjornsdottir US, Holm H, Kristjansson K, Frigge ML, Kristvinsson H, Gulcher JR, Jonsson T, Rafnar T, Hjartarsson H, Mayordomo JI, de la Chapelle A, Hrafnkelsson J, Thorsteinsdottir U, Kong A, Stefansson K.

Nat Genet. 2009 Apr;41(4):460-4. doi: 10.1038/ng.339. Epub 2009 Feb 6.

4.

Sequence variants at the TERT-CLPTM1L locus associate with many cancer types.

Rafnar T, Sulem P, Stacey SN, Geller F, Gudmundsson J, Sigurdsson A, Jakobsdottir M, Helgadottir H, Thorlacius S, Aben KK, Blöndal T, Thorgeirsson TE, Thorleifsson G, Kristjansson K, Thorisdottir K, Ragnarsson R, Sigurgeirsson B, Skuladottir H, Gudbjartsson T, Isaksson HJ, Einarsson GV, Benediktsdottir KR, Agnarsson BA, Olafsson K, Salvarsdottir A, Bjarnason H, Asgeirsdottir M, Kristinsson KT, Matthiasdottir S, Sveinsdottir SG, Polidoro S, Höiom V, Botella-Estrada R, Hemminki K, Rudnai P, Bishop DT, Campagna M, Kellen E, Zeegers MP, de Verdier P, Ferrer A, Isla D, Vidal MJ, Andres R, Saez B, Juberias P, Banzo J, Navarrete S, Tres A, Kan D, Lindblom A, Gurzau E, Koppova K, de Vegt F, Schalken JA, van der Heijden HF, Smit HJ, Termeer RA, Oosterwijk E, van Hooij O, Nagore E, Porru S, Steineck G, Hansson J, Buntinx F, Catalona WJ, Matullo G, Vineis P, Kiltie AE, Mayordomo JI, Kumar R, Kiemeney LA, Frigge ML, Jonsson T, Saemundsson H, Barkardottir RB, Jonsson E, Jonsson S, Olafsson JH, Gulcher JR, Masson G, Gudbjartsson DF, Kong A, Thorsteinsdottir U, Stefansson K.

Nat Genet. 2009 Feb;41(2):221-7. doi: 10.1038/ng.296. Epub 2009 Jan 18.

5.

Mutational analysis of a principal neutralization domain of visna/maedi virus envelope glycoprotein.

Haflidadóttir BS, Matthíasdóttir S, Agnarsdóttir G, Torsteinsdóttir S, Pétursson G, Andrésson OS, Andrésdóttir V.

J Gen Virol. 2008 Mar;89(Pt 3):716-21. doi: 10.1099/vir.0.83410-0.

PMID:
18272763
6.

Vaccination of sheep with Maedi-visna virus gag gene and protein, beneficial or harmful?

Torsteinsdóttir S, Carlsdóttir HM, Svansson V, Matthíasdóttir S, Martin AH, Pétursson G.

Vaccine. 2007 Sep 17;25(37-38):6713-20. Epub 2007 Jul 26.

PMID:
17686553
7.

A common variant on chromosome 9p21 affects the risk of myocardial infarction.

Helgadottir A, Thorleifsson G, Manolescu A, Gretarsdottir S, Blondal T, Jonasdottir A, Jonasdottir A, Sigurdsson A, Baker A, Palsson A, Masson G, Gudbjartsson DF, Magnusson KP, Andersen K, Levey AI, Backman VM, Matthiasdottir S, Jonsdottir T, Palsson S, Einarsdottir H, Gunnarsdottir S, Gylfason A, Vaccarino V, Hooper WC, Reilly MP, Granger CB, Austin H, Rader DJ, Shah SH, Quyyumi AA, Gulcher JR, Thorgeirsson G, Thorsteinsdottir U, Kong A, Stefansson K.

Science. 2007 Jun 8;316(5830):1491-3. Epub 2007 May 3.

8.

Duplicated sequence motif in the long terminal repeat of maedi-visna virus extends cell tropism and is associated with neurovirulence.

Oskarsson T, Hreggvidsdóttir HS, Agnarsdóttir G, Matthíasdóttir S, Ogmundsdóttir MH, Jónsson SR, Georgsson G, Ingvarsson S, Andrésson OS, Andrésdóttir V.

J Virol. 2007 Apr;81(8):4052-7. Epub 2007 Feb 7.

9.

Simultaneous mutations in CA and Vif of Maedi-Visna virus cause attenuated replication in macrophages and reduced infectivity in vivo.

Gudmundsson B, Jónsson SR, Olafsson O, Agnarsdóttir G, Matthíasdóttir S, Georgsson G, Torsteinsdóttir S, Svansson V, Kristbjornsdóttir HB, Franzdóttir SR, Andrésson OS, Andrésdóttir V.

J Virol. 2005 Dec;79(24):15038-42.

10.

Mucosal vaccination with an attenuated maedi-visna virus clone.

Pétursson G, Matthíasdóttir S, Svansson V, Andrésdóttir V, Georgsson G, Martin AH, Agnarsdóttir G, Gísladóttir E, Arnadóttir S, Högnadóttir S, Jónsson SR, Andrésson OS, Torsteinsdóttir S.

Vaccine. 2005 May 2;23(24):3223-8.

PMID:
15837223
11.

The vif gene of maedi-visna virus is essential for infectivity in vivo and in vitro.

Kristbjörnsdóttir HB, Andrésdóttir V, Svansson V, Torsteinsdóttir S, Matthíasdóttir S, Andrésson OS.

Virology. 2004 Jan 5;318(1):350-9.

12.

Intratracheal inoculation as an efficient route of experimental infection with maedi-visna virus.

Torsteinsdóttir S, Matthíasdóttir S, Vidarsdóttir N, Svansson V, Pétursson G.

Res Vet Sci. 2003 Dec;75(3):245-7.

PMID:
13129674
13.

Selection of antigenic variants in maedi-visna virus infection.

Andrésdóttir V, Skraban R, Matthíasdóttir S, Lutley R, Agnarsdóttir G, Thorsteinsdóttir H.

J Gen Virol. 2002 Oct;83(Pt 10):2543-51.

PMID:
12237438
14.

The long terminal repeat is a determinant of cell tropism of maedi-visna virus.

Agnarsdóttir G, Thorsteinsdóttir H, Oskarsson T, Matthíasdóttir S, Haflidadóttir BS, Andrésson OS, Andrésdóttir V.

J Gen Virol. 2000 Aug;81(Pt 8):1901-5.

PMID:
10900026
15.

Naturally occurring mutations within 39 amino acids in the envelope glycoprotein of maedi-visna virus alter the neutralization phenotype.

Skraban R, Matthíasdóttir S, Torsteinsdóttir S, Agnarsdóttir G, Gudmundsson B, Georgsson G, Meloen RH, Andrésson OS, Staskus KA, Thormar H, Andrésdóttir V.

J Virol. 1999 Oct;73(10):8064-72.

16.

Biological and genetic differences between lung- and brain-derived isolates of maedi-visna virus.

Andrésdóttir V, Tang X, Agnarsdóttir G, Andrésson OS, Georgsson G, Skraban R, Torsteinsdóttir S, Rafnar B, Benediktsdóttir E, Matthíasdóttir S, Arnadóttir S, Högnadóttir S, Pálsson PA, Pétursson G.

Virus Genes. 1998;16(3):281-93.

PMID:
9654682
17.

Visna virus dUTPase is dispensable for neuropathogenicity.

Pétursson G, Turelli P, Matthíasdóttir S, Georgsson G, Andrésson OS, Torsteinsdóttir S, Vigne R, Andrésdóttir V, Gunnarsson E, Agnarsdóttir G, Quérat G.

J Virol. 1998 Feb;72(2):1657-61.

18.

In vivo and in vitro infection with two different molecular clones of visna virus.

Torsteinsdóttir S, Agnarsdóttir G, Matthíasdóttir S, Rafnar B, Andrésdóttir V, Andrésson OS, Staskus K, Pétursson G, Pálsson PA, Georgsson G.

Virology. 1997 Mar 17;229(2):370-80.

Supplemental Content

Loading ...
Support Center